Cargando…

Relapsing encephalomyelitis following transfer of partial immunity to JHM virus()

Mice infected with the JHM strain mouse hepatitis virus (JHMV) develop a fatal encephalomyelitis with evidence of demyelination. It has previously been shown that the adoptive transfer of 5 × 10(7) nylon wool adherent (NWA) spleen cells from immunized donors to lethally infected recipients clears vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shubin, Richard A., Sussman, Mark A., Fleming, John O., Stohlman, Stephen A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 1990
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135167/
https://www.ncbi.nlm.nih.gov/pubmed/1977071
http://dx.doi.org/10.1016/0882-4010(90)90089-9
_version_ 1783517994549248000
author Shubin, Richard A.
Sussman, Mark A.
Fleming, John O.
Stohlman, Stephen A.
author_facet Shubin, Richard A.
Sussman, Mark A.
Fleming, John O.
Stohlman, Stephen A.
author_sort Shubin, Richard A.
collection PubMed
description Mice infected with the JHM strain mouse hepatitis virus (JHMV) develop a fatal encephalomyelitis with evidence of demyelination. It has previously been shown that the adoptive transfer of 5 × 10(7) nylon wool adherent (NWA) spleen cells from immunized donors to lethally infected recipients clears virus from the central nervous system (CNS) and prevents demyelination. Adoptive transfer of a smaller number (1 × 10(7)) of NWA spleen cells from immunized donors also protects from death but does not significantly alter virus replication in the CNS during the acute phase of the infection. Moreover, these mice develop a transient non-fatal encephalomyelitis which occurs approximately 3 weeks post-infection. This delayed encephalomyelitis is associated with a mononuclear cell infiltration into the CNS but little or no evidence of virus replication or increased viral antigen. A virus-specific delayed-type hypersensitivity (DTH) response precedes this delayed onset of disease by 24 to 48 h. Resolution of disease correlates with a selective and permanent suppression of the JHMV-specific DTH reactivity. In addition, no virus-specific DTH is detected following adoptive transfer of viral-specific DTH effectors derived from immunized donors. In contrast, these mice respond to a heterologous antigen, KLH, suggesting that the resolution of the encephalitis is accompanied by a profound suppression in viral-specific DTH response.
format Online
Article
Text
id pubmed-7135167
institution National Center for Biotechnology Information
language English
publishDate 1990
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71351672020-04-08 Relapsing encephalomyelitis following transfer of partial immunity to JHM virus() Shubin, Richard A. Sussman, Mark A. Fleming, John O. Stohlman, Stephen A. Microb Pathog Article Mice infected with the JHM strain mouse hepatitis virus (JHMV) develop a fatal encephalomyelitis with evidence of demyelination. It has previously been shown that the adoptive transfer of 5 × 10(7) nylon wool adherent (NWA) spleen cells from immunized donors to lethally infected recipients clears virus from the central nervous system (CNS) and prevents demyelination. Adoptive transfer of a smaller number (1 × 10(7)) of NWA spleen cells from immunized donors also protects from death but does not significantly alter virus replication in the CNS during the acute phase of the infection. Moreover, these mice develop a transient non-fatal encephalomyelitis which occurs approximately 3 weeks post-infection. This delayed encephalomyelitis is associated with a mononuclear cell infiltration into the CNS but little or no evidence of virus replication or increased viral antigen. A virus-specific delayed-type hypersensitivity (DTH) response precedes this delayed onset of disease by 24 to 48 h. Resolution of disease correlates with a selective and permanent suppression of the JHMV-specific DTH reactivity. In addition, no virus-specific DTH is detected following adoptive transfer of viral-specific DTH effectors derived from immunized donors. In contrast, these mice respond to a heterologous antigen, KLH, suggesting that the resolution of the encephalitis is accompanied by a profound suppression in viral-specific DTH response. Published by Elsevier Ltd. 1990-05 2004-02-10 /pmc/articles/PMC7135167/ /pubmed/1977071 http://dx.doi.org/10.1016/0882-4010(90)90089-9 Text en Copyright © 1990 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Shubin, Richard A.
Sussman, Mark A.
Fleming, John O.
Stohlman, Stephen A.
Relapsing encephalomyelitis following transfer of partial immunity to JHM virus()
title Relapsing encephalomyelitis following transfer of partial immunity to JHM virus()
title_full Relapsing encephalomyelitis following transfer of partial immunity to JHM virus()
title_fullStr Relapsing encephalomyelitis following transfer of partial immunity to JHM virus()
title_full_unstemmed Relapsing encephalomyelitis following transfer of partial immunity to JHM virus()
title_short Relapsing encephalomyelitis following transfer of partial immunity to JHM virus()
title_sort relapsing encephalomyelitis following transfer of partial immunity to jhm virus()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135167/
https://www.ncbi.nlm.nih.gov/pubmed/1977071
http://dx.doi.org/10.1016/0882-4010(90)90089-9
work_keys_str_mv AT shubinricharda relapsingencephalomyelitisfollowingtransferofpartialimmunitytojhmvirus
AT sussmanmarka relapsingencephalomyelitisfollowingtransferofpartialimmunitytojhmvirus
AT flemingjohno relapsingencephalomyelitisfollowingtransferofpartialimmunitytojhmvirus
AT stohlmanstephena relapsingencephalomyelitisfollowingtransferofpartialimmunitytojhmvirus